|Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease||
||99||All||30 Years and older (Adult, Senior)||NCT00909545||CTCC Protocol #124||STEADY-PD||July 2009||December 2011||February 2012||May 28, 2009||April 17, 2013||April 17, 2013||
|2||NCT00528086||Completed||A Pilot, Randomized Controlled Trial of Group Visits for Persons With Parkinson's Disease||
||40||All||30 Years and older (Adult, Senior)||NCT00528086||RSRB00019885||GROUP-PD||September 2007||August 2009||August 2009||September 11, 2007||May 25, 2010||
† Study has passed its completion date and status has not been verified in more than two years.